CurrentCareSourcePolicy N/A

Negative Pressure Wound Therapy (NPWT) Coverage Criteria

Defines medical necessity, coverage criteria, limitations, and supply allowances for Negative Pressure Wound Therapy for CareSource Arkansas PASSE members.

Policy Summary

PayerCareSource

PolicyNegative Pressure Wound Therapy (NPWT) Coverage Criteria

Policy CodePolicy N/A

Change TypeMinor or no material changes

Effective DateJan 1, 2022

Next Review DateN/A

Key ActionObtain prior authorization documenting eligible wound type, prior conservative measures, and required documentation for continuation.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Stage III/IVpressure ulcer stages eligible for NPWT

15dressing kits per wound per 31 days

10canister sets per 31 days

$25Bannual US wound spending

MM-1144referenced internal policy

Negative Pressure Wound Therapy — Coverage Criteria

Eligible Wound Types and Required Preconditions

Covered when the following wound-type specific criteria are met

Pressure ulcers: Stage III or IV pressure ulcer

AND member meets ALL of the following preconditions: every-2-hour turning/repositioning regimen; incontinence and moisture management; pressure relief techniques/surfaces ordered and documented with ongoing compliance (e.g., foam overlay, low-air-loss devices)

Chronic neuropathic ulcer: Neuropathic ulcer in diabetic patients

AND a comprehensive diabetic management program has been implemented including A1C management, medication management, and ongoing diabetic education

Venous or arterial insufficiency ulcers: Ulcers related to venous or arterial insufficiency

AND foot care by a medical professional including inspection, nail care, pressure reduction on foot ulcer, and monofilament testing; for venous insufficiency, consistent compression therapy documented for at least 30 days

Policy Summary

PayerCareSource

PolicyNegative Pressure Wound Therapy (NPWT) Coverage Criteria

Policy CodePolicy N/A

Change TypeMinor or no material changes

Effective DateJan 1, 2022

Next Review DateN/A

Key ActionObtain prior authorization documenting eligible wound type, prior conservative measures, and required documentation for continuation.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Continuation of NPWT

Continuation criteria

Continuation prerequisites: Documentation that a licensed medical professional directly performed the dressing change AND documentation of measurable improvement in wound healing or documentation of debridement within the prior approval period

Measurable improvement defined as changes in drainage; inflammation; swelling; pain/tenderness; wound dimensions (length x width) or depth; granulation tissue; necrotic tissue/slough; or tunneling/undermining; wound must show progressive and measurable improvement

Exception to measurable improvement: If no measurable improvement, continuation may be supported when documentation shows the wound was debrided within the last approval period

Before-and-after images are preferred

Prior Authorization, Documentation, and Billing Guidance

Prior Authorization

Prior Authorization Required

Prior authorization is required. Requests must document that the member meets the clinical criteria for NPWT and that conservative measures have been tried (see conservative therapy callout). Ensure prior auth submission includes wound staging, diagnosis, prior treatments, and the specific clinical justification for NPWT.

Prior authorization must demonstrate ALL applicable clinical criteria are met for the requested indication.
Include documentation of prior conservative measures (turning/repositioning, pressure-relief surfaces, incontinence/moisture management) and compliance.
Attach recent wound measurements, photographs, and treating licensed professional's notes.

Prior Authorization

Conservative Therapy Prerequisites

Before initiating NPWT, document that conservative therapies were attempted and the member was compliant. Examples include turning/repositioning regimens, appropriate support/pressure-relief surfaces, and management of incontinence/moisture.

Member on an every-2-hour turning and repositioning regimen where applicable.
Documentation of ordered and used pressure-reducing surfaces (foam overlay, low-air-loss, etc.) and evidence of ongoing compliance in the medical record.
Incontinence and moisture management strategies have been implemented and documented.

Documentation Required

Required Documentation for Continuation

For approval of continued NPWT beyond the initial authorization period, submit documentation from a licensed medical professional showing that dressing changes were performed and that the wound demonstrates measurable improvement.

Licensed medical professional has directly performed dressing changes (note provider name, credentials, and dates).
Measurable improvement documented in at least one of: drainage, inflammation, swelling, pain/tenderness, wound dimensions (length × width), depth, granulation tissue, necrotic tissue/slough, tunneling or undermining.
If no measurable improvement, include documentation of any debridement performed during the prior approval period (before-and-after images preferred) and clinical rationale for continued NPWT.

Denial Risk

Absolute Non-Coverage Conditions

NPWT is NOT covered for wounds with the following absolute conditions. Presence of any of these contraindications makes NPWT not medically necessary and will result in noncoverage.

Exposed nerves, blood vessels, or organs in the vicinity of the wound.
Active, uncontrolled bleeding.
Active infection in the wound or osteomyelitis that is not being concurrently treated with intent to cure.
Uncontrolled soft tissue infection or osteomyelitis within the vicinity of the wound.
Malignancy present in the wound.
Open fistula to an organ or body cavity in the vicinity of the wound.
Necrotic tissue with eschar that has not been debrided.

Billing Rule

Intraoperative Application Billing

NPWT applied intraoperatively is considered included in the primary surgical procedure and is not separately reimbursable. Submit requests for postoperative/continuation NPWT separately with required documentation.

NPWT used during surgery is bundled into the surgical code — do not bill separately.
Requests for continued NPWT after the initial 31-day period require documentation per continuation criteria.

Key Definitions

Neuropathic Ulcer (inv-15)

DefinitionUlcer due to lack of sensation secondary to neuropathy causing skin and underlying tissue breakdown, often complicated by infection

Typical contextCommon in diabetic patients where loss of protective sensation leads to unrecognized trauma and ulceration

Clinical relevanceRequires comprehensive diabetic management and foot care prior to NPWT initiation per coverage criteria

Arterial Insufficiency Ulcer (inv-16)

DefinitionUlcer that develops due to inadequate delivery of oxygen-rich blood to the tissue, leading to tissue deterioration and open wounds

PathophysiologyCaused by arterial insufficiency resulting in ischemia and poor wound healing potential

Coverage noteRequires foot care by a medical professional and vascular management as part of prerequisites for NPWT

Venous Insufficiency Ulcer (inv-17)

DefinitionUlcer due to dysfunctional venous valves causing venous dilation and blood pooling, which leads to protein leakage and subcutaneous tissue deterioration

Typical locationTypically occurs in the lower limbs due to venous hypertension and valve insufficiency

Coverage noteConsistent compression therapy documented for at least 30 days is required for NPWT consideration in venous ulcers

Stage III/IV Pressure Ulcer definitions (inv-18)

Stage IIIFull-thickness loss of skin; adipose (fat) tissue and granulation tissue may be visible; wound edges often rolled (epibole); eschar and slough may be present; undermining and tunneling may occur; fascia, muscle, tendon, ligament should not be exposed

Stage IVFull-thickness tissue loss with exposed or directly palpable bone, tendon, or muscle; wound edges often rolled; eschar and slough typically present; undermining and tunneling common

Staging importanceStages III and IV are the pressure ulcer stages eligible for NPWT per coverage criteria

OpenPayer

Negative Pressure Wound Therapy (NPWT) Coverage Criteria

Negative Pressure Wound Therapy — Coverage Criteria

Coding and Supply Limits

Prior Authorization, Documentation, and Billing Guidance

Background

Key Definitions